Fatal cases in pediatric patients after post-exposure prophylaxis for rabies: A report of two cases

Abstract

Rationale: Rabies is a zoonotic disease with a high mortality, primarily transmitted through the bite of infected mammals, particularly dogs and cats. Despite being a well-known disease since ancient times, it continues to cause a significant number of human deaths worldwide, with approximately 65 000 fatalities reported annually.

Patient concerns: We present two fatal cases of rabies in a 12-year- old immigrant boy and a 7-year-old boy. The first case was subject to a 24-hour delay in receiving appropriate medical attention and rabies preventive measures due to the lack of awareness among emergency hospital staff, leading to the administration of wound dressing only. The second case received timely rabies immunoglobulin administration; however, there was a 4-day delay in administering the fourth dose of the rabies vaccine, despite presenting evident symptoms of rabies.

Diagnosis: Postmortem examination of brain samples from both patients confirmed the presence of rabies virus.

Interventions: Post-exposure prophylaxis for rabies.

Outcomes: Both patients were admitted to the hospital after the manifestation of rabies-related symptoms, with the 12-year-old child seeking medical care 47 days after the animal bite and the 7-year-old child seeking medical care 58 days after the exposure. Finally, the first patient died after 27 days and the second patient died after 40 days of hospitalization.

Lessons: There is an urgent need for heightened awareness and education among both healthcare professionals and the public regarding the urgency of seeking immediate medical attention after potential rabies exposure. Timely recognition and initiation of post-exposure prophylaxis are pivotal in preventing the progression of the disease. Strengthening surveillance and reporting systems, coupled with continuous training for healthcare professionals, can contribute to early detection and management of rabies cases.

Keywords

Rabies / Encephalitis / Pediatric patients / Rabies prophylaxis / Public health awareness.

References

[1] Whitehouse ER, Mandra A, Bonwitt J, Beasley EA, Taliano J, Rao AK. Human rabies despite post-exposure prophylaxis: A systematic review of fatal breakthrough infections after zoonotic exposures. Lancet Infect Dis 2023; 23(5): 167-174.

[2] Rahpeyma M, Farahtaj F, Fazeli M, Sheikh-o-leslami F, Bashar R, Howaizi N, et al. Epidemiological study of rabies infection in specimens sent to Pasteur Institute of Iran in 2015. J Babol Univ Med Sci 2015; 17(12): 65-70.

[3] Mani RS, Damodar T, Domala S, Gurung B, Jadhav V, Konanki R, et al. Case reports: Survival from rabies: Case series from India. Am J Trop Med Hyg 2019; 100(1): 165-169.

[4] Raynor B, Díaz EW, Shinnick J, Zegarra E, Monroy Y, Mena C, et al. The impact of the COVID-19 pandemic on rabies reemergence in Latin America: The case of Arequipa, Peru. PLoS Negl Trop Dis 2021; 15(5): 1-13.

[5] Singh R, Singh KP, Cherian S, Saminathan M, Kapoor S, Manjunatha Reddy GB, et al. Rabies-epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: A comprehensive review. Vet Q 2017; 37(1): 212-251.

[6] Chawla T, Sehgal J, Dabla S, Goyal V. Acute motor axonal neuropathy following anti-rabies human diploid cell vaccine: A rare case and review. Asian Pac J Trop Med 2022; 15(9): 425-426.

[7] Bookstaver PB, Akpunonu P, Nguyen HB, Swan JT, Howington GT. Administration of rabies immunoglobulin: Improving evidence-based guidance for wound infiltration. Pharmacotherapy 2021; 41(8): 644-648.

[8] Velasco-Villa A, Messenger SL, Orciari LA, Niezgoda M, Blanton JD, Fukagawa C, et al. New rabies virus variant in Mexican immigrant. Emerg Infect Dis 2008; 14(12): 1906-1908.